A Crossover Study in the Treatment of Patients With COPD

Completed · Phase 3

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

The purpose of this study is to compare the efficacy of Formoterol Fumarate Inhalation Solution (FFIS) 20 mcg BID to Combivent® Inhalation Aerosol \[2 inhalations from metered dose inhaler (MDI)of 18 mcg ipratropium bromide and 103 mcg albuterol sulfate QID\], and to Compare the preference/compliance of BID nebulization to QID use of MDI

Key facts

Study ID: NCT00462540
Run by: Dey
People needed: 100
Starts: 2007-05-01
Expected to finish: 2007-10-01
Last updated by the study team: 2009-03-04

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Diagnosis of COPD
Smoker or exsmoker with at least 10 years smoking at least one pack of cigarettes per day
Meet lung function requirements

You may not qualify if…

Diagnosis of Asthma
Significant disease other than COPD
Female pregnant or lactating or planning to become pregnant

Where it is running

Research Site — San Diego, California, United States
Research Site — Denver, Colorado, United States
Research Site — Wheat Ridge, Colorado, United States
Research Site — Panama City, Florida, United States
Research Site — Pensacola, Florida, United States
Research Site — Coeur d'Alene, Idaho, United States
Research Site — Sunset, Louisiana, United States
Research Site — Charlotte, North Carolina, United States
Research Site — Portland, Oregon, United States
Research Site — Gaffney, South Carolina, United States
Research Site — Spartanburg, South Carolina, United States
Research Site — Johnson City, Tennessee, United States
Research Site — San Antonio, Texas, United States
Research Site — Spokane, Washington, United States
Research Site — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.